2
Clinical Trials associated with Rotavirus vaccine, inactivated(Zhifei Biological)单中心、随机、双盲、安慰剂对照、剂量递增I期临床试验评价6周龄~49岁人群应用轮状病毒灭活疫苗的安全性与耐受性
[Translation] A single-center, randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial to evaluate the safety and tolerability of inactivated rotavirus vaccine in people aged 6 weeks to 49 years
评价轮状病毒灭活疫苗的安全性与耐受性并初步探索免疫原性。
[Translation] To evaluate the safety and tolerability of inactivated rotavirus vaccine and preliminarily explore its immunogenicity.
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evalution the Safety, Tolerability of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
The research objective is to evaluate the safety and tolerability of the inactivated rotavirus vaccine and explore its preliminary immunogenicity.
100 Clinical Results associated with Rotavirus vaccine, inactivated(Zhifei Biological)
100 Translational Medicine associated with Rotavirus vaccine, inactivated(Zhifei Biological)
100 Patents (Medical) associated with Rotavirus vaccine, inactivated(Zhifei Biological)
100 Deals associated with Rotavirus vaccine, inactivated(Zhifei Biological)